Agilent Technologies Inc. (A) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with i...
Agilent Technologies Inc.'s revenue increased 6.7% year over year, from $6.51B to $6.95B.
Net income increased 1.1% over the same period, from $1.29B to $1.30B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 65% in total.
Total debt remained relatively stable at $3.35B.
The debt-to-equity ratio stands at 0.50, indicating a moderate leverage profile.
Operating cash flow declined 11.0% to $1.56B.
Agilent Technologies Inc. maintains a healthy net profit margin of 18.8%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2024 | $1.66B-67.8% | $348.0M | $908.0M | $384.0M | $485.0M | $10.95B | $2.56B | $6.19B |
| Q2 FY2024 | $3.23B+94.9% | $656.0M | $1.76B | $747.0M | $818.0M | $10.86B | $2.56B | $6.21B |
| Q3 FY2024 | $4.81B+48.8% | $938.0M | $2.62B | $1.08B | $1.27B | $11.00B | $2.93B | $5.90B |
| Q1 FY2025 | $1.68B-65.0% | $318.0M | $899.0M | $376.0M | $431.0M | $11.91B | $3.36B | $6.03B |
| Q2 FY2025 | $3.35B+99.2% | $533.0M | $1.76B | $676.0M | $652.0M | $12.16B | $3.50B | $6.14B |
| Q3 FY2025 | $5.09B+51.9% | $869.0M | $2.65B | $1.04B | $1.01B | $12.23B | $3.41B | $6.37B |
| Q1 FY2026 | $1.80B-64.7% | $305.0M | $946.0M | $353.0M | $268.0M | $12.81B | $3.35B | $6.91B |
| Q2 FY2026 | $3.63B+102.1% | $644.0M | $1.94B | $752.0M | $545.0M | $13.06B | $3.35B | $7.12B |
Balance Sheet Summary (Latest Period)
Total Assets
$12.73B
Total Liabilities
$5.99B
Total Equity
$6.74B
Cash & Equivalents
$1.79B
Total Debt
$3.35B
Current Assets
$4.59B
Current Liabilities
$2.35B
Retained Earnings
$1.39B